Category Specific RSS

ASX:RCE

Recce Pharmaceuticals Accelerates Commercialisation with Strong Phase II Trial Results

USD 26 Billion Market Opportunity The global market for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) is expected to…

8 months ago